Navigation Links
Sanofi and Regeneron Report Positive Phase 2b Trial Results with Sarilumab in Rheumatoid Arthritis
Date:7/12/2011

 Studies suggest that blockade of IL-6 signaling, one of several key cytokines involved in the inflammatory processes related to RA, may reduce inflammation of the joints, prevent long-term damage and relieve certain systemic effects of RA such as decreased hemoglobin, fatigue and osteoporosis.

About the ALIGN TrialThe 300-patient ALIGN trial is a randomized, double-blind, placebo-controlled, dose ranging study to evaluate the efficacy and safety of sarilumab in patients with AS who had an inadequate response to NSAIDs.  The primary outcome measure of the trial was the percentage of patients who achieved a 20% improvement in AS International Working Group Criteria for improvement (ASAS20) at 12 weeks.  The secondary endpoints included ASAS40 response, partial remission, and changes in disease activity, safety and tolerability.  In the ALIGN trial, the same dose regimens were tested as in part A of the MOBILITY trial.  Further details about the ALIGN trial can be found at http://clinicaltrials.gov/ct2/results?term=SAR153191+align.

About SanofiSanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs.  Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, rare diseases, consumer healthcare, emerging markets and animal health.  Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).

About Regeneron Pharmaceuticals, Inc.Regeneron is a fully integrated biopharmaceutical company that discovers, develops, and commercializes medicines for the treatment of serious medical conditions.  In addition to ARCALYST® (rilonacept) Injection for Subcutaneous Use, its first commercialized product, Regeneron has therapeutic candidates in Phase III clinical
'/>"/>

SOURCE Regeneron Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Sanofi Divests Dermik Dermatology Unit to Valeant Pharmaceuticals International, Inc.
2. Sanofi Enters Into Research Collaboration with Weill Cornell Medical College to Discover New Treatments for Tuberculosis
3. Sanofi Pasteur Commends Winners of International BioGENEius Challenge
4. Sanofi Announces Positive Results from the "All to Target" Study Evaluating Two Lantus® and Apidra® Regimens Versus Premixed Regimen
5. Medco, United BioSource and Sanofi Signed Global Agreement to Improve Quality of Patient Care Through Real-World Evidence
6. Sanofi Enters Into Research Collaboration With Biopharmaceutical Company Audion Therapeutics to Develop Potential Treatments for Hearing Loss
7. Sanofi Pasteur Donates Tdap Vaccine to Aid Storm Victims
8. sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011
9. Sanofi Pasteur Announces FDA Approval of Menactra Meningococcal Conjugate Vaccine Indication for Infants
10. Sanofi-aventis Enters into Collaboration Agreement with Stanford University Bio-X to Focus on Early-Stage Scientific Research
11. Sanofi-Aventis Completes Acquisition of Genzyme Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... 2014 Northstar Global Business Services, Inc., ... of hard work from many talented specialists, the ... and package design.  The new formulation for Snorenz ... the product due to overwhelming evidence of increased ... Nighttime will also include these vitamins, as well ...
(Date:8/20/2014)... Aug. 20, 2014  The National Association of ... results achieved by the real-time, pseudoephedrine (PSE) blocking ... Precursor Log Exchange (NPLEx), automatically blocks unlawful PSE ... meth offenders and make arrests. Data released by ... blocked the sale of more than ...
(Date:8/20/2014)... 20, 2014  The National Association of Drug ... achieved by the real-time, pseudoephedrine (PSE) blocking system ... Log Exchange (NPLEx), automatically blocks unlawful pseudoephedrine sales ... offenders and make arrests. Data released by NPLEx ... blocked the sale of more than 19,030 ...
Breaking Medicine Technology:Northstar completes the first phase of its new retail strategy and prepares to ship reformulated Snorenz with all new packaging 2Kentucky's Stop-Sale System Achieves Significant Results In Battle Against Meth 2Missouri's Stop-Sale System Achieves Significant Results In Battle Against Meth 2
... June 2 The Female Health Company (Nasdaq: FHCO ) announced that ... for HIV/AIDS prevention to attendees at the 2010 World Cup. The 2010 World Cup ... 11, 2010 to July 11, 2010 . , ... The month-long 2010 World Cup, which offers three million tickets to the games, ...
... 2 PolyGel® is proud to announce that their new ThermoActive™ Plus ... , , ... , , ... market that simultaneously combines the support of a lumbar orthosis with the ability ...
Cached Medicine Technology:The Female Health Company Receives Order for 3.5 Million FC2 Female Condoms for Distribution at 2010 World Cup 2The Female Health Company Receives Order for 3.5 Million FC2 Female Condoms for Distribution at 2010 World Cup 3PolyGel® Receives SADMERC Approval for L-Code L0627 for New ThermoActive™ Plus Cold & Hot Compression Lumbar Orthosis 2
(Date:8/21/2014)... CO (PRWEB) August 21, 2014 Aspen Advisors, ... been selected as one of Modern Healthcare’s Best Places ... program recognizes employers in the healthcare industry for creating workplaces ... Results are solely based on employee responses to an employee ... year that Aspen has been named a “Best ...
(Date:8/21/2014)... by T-type calcium channels in the thalamic reticular ... calcium. These channels enable thalamic reticular nucleus neurons ... enter a hyper-excited state. , In order to ... seizures, the researchers conducted an experiment to induce ... to delete the T-type calcium channel CaV3.3. The ...
(Date:8/21/2014)... to researchers at the University of Montreal, the regions ... role as we train our bodies, movements and, critically, ... While researchers knew that sleep helped us the learn ... why. "The subcortical regions are important in information consolidation, ... consolidation level is measured after a period of sleep, ...
(Date:8/21/2014)... Bedros Keuilian’s Annual Fitness Business Summit is considered the ... people already earning seven-figure incomes. But his annual Fit ... to the owners of Keuilian’s own international fitness boot camp ... Boot Camp World Conference will also be attended by 50 ... or are struggling with their own boot camp businesses. ...
(Date:8/21/2014)... Hunhu Healthcare, Inc. , a Minneapolis-based ... it has entered into a licensing agreement with Mayo ... predictive analytics for recruiting, leveraging and managing its solution ... Michael Emerson , co-founder and CEO of Hunhu Healthcare, ... technology used in what he calls a social wellness ...
Breaking Medicine News(10 mins):Health News:Modern Healthcare Names Aspen Advisors Among the Top 100 Employers in the Healthcare Industry for a Fourth Consecutive Year 2Health News:Learning to play the piano? Sleep on it! 2Health News:Fitness Boot Camp Founder Offers Fifty Scholarships to Fit Body Boot Camp World Conference 2Health News:Fitness Boot Camp Founder Offers Fifty Scholarships to Fit Body Boot Camp World Conference 3Health News:Hunhu Healthcare Enters into Licensing Agreement with Mayo Clinic 2
... have discovered a second gene that causes Alagille syndrome, ... many organs.// , This finding may have broader ... Hospital team had earlier discovered the first gene associated ... mutations in the NOTCH 2 gene were linked to ...
... 9,000 Danish residents revealed that a specific mutation in the ... breast cancer in her lifetime. The study, which was the ... the cancer risk associated with it, in the general population, ... Journal of Clinical Oncology. ,"Our study shows ...
... University of Georgia have suggested that cross-immunity created in ... protect against infection //,by related serotypes thus leading to ... This finding would help understand the pattern of this ... about the mid 1980s, there's been a sequential replacement ...
... nicotine dependence can develop in some smokers right after ... Smoking cessation programs for teenagers have had little ... the cessation programs aimed at youngsters for the programs ... use has traditionally been thought to progress through 5 ...
... listed on food labels to help cut heart disease, according ... experts putting forward their arguments in this week's British Medical ... combat the UK's number one killer, estimated to be responsible ... ,In addition cardiovascular disease is reported to cost the ...
... medically shocking incident, a 35-year-old woman in Madhya Pradesh survived ... was however operated upon Friday at the government hospital at ... a kilo-and-half was finally removed from her womb. ... menstrual cycle started in the seventh month of her pregnancy, ...
Cached Medicine News:Health News:Second Alagille Syndrome Gene discovered: More information on kidney disease 2Health News:CHEK 2 Gene Mutation Triples Breast Cancer Risk 2Health News:Waxing And Waning Of Dengue Epidemics Attributed To Cross-Immunity 2Health News:Waxing And Waning Of Dengue Epidemics Attributed To Cross-Immunity 3Health News:Scientists Push for Labeling of all Fats to Avoid Heart Disease 2
... Speed Pre and Post High Vacuum Autoclaves. ... designed to cover a large of applications ... well as private clinics and dental offices. ... of medical and surgical materials such as ...
... manual autoclaves set the standard for steam ... to compliment any healthcare and laboratory facility. ... of your sterilization needs. Time tested reliability ... product. The Tuttnauer M Series is also ...
... is a confocal laser scanning microscope ... images of the posterior segment. It ... retinal topography and precise follow-up of ... routine application of Heidelberg Retina Tomograph ...
Subjective refraction unit, computer controlled and programmable. Two versions: with and without prisms....
Medicine Products: